For the fifth annual Nixon National Cancer Conference, the Richard Nixon Foundation partnered with the Milken Institute in February to host Cancer 2035: A Roadmap for the Future. The event coincided with the 55th anniversary of the National Cancer Act — landmark legislation signed by President Richard Nixon that transformed the nation’s approach to cancer and set in motion decades of scientific and clinical progress.
We are pleased to share the report emerging from this convening, which identifies seven key priorities to advance the next era of cancer innovation — spanning federal leadership, data and AI infrastructure, clinical trial modernization, next-generation therapies, prevention and early detection, equitable access, and trust-building across the ecosystem.
A sincere thank you to the Milken Institute for their partnership in advancing this important legacy of President Nixon.
Watch the full conference here:
